SINONASAL UNDIFFERENTIATED CARCINOMA

Clinical trials for SINONASAL UNDIFFERENTIATED CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new SINONASAL UNDIFFERENTIATED CARCINOMA trials appear

Sign up with your email to follow new studies for SINONASAL UNDIFFERENTIATED CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet finished but already full! 1

New combo attack on tough cancers: radiation meets targeted drug

Disease control Recruiting now

This study is testing whether it is safe to combine a new targeted drug called tarlatamab with standard radiation therapy. It is for adults with advanced cancers that have a specific protein called DLL3, including certain lung cancers, melanoma, and others. The main goal is to se…

Matched conditions: SINONASAL UNDIFFERENTIATED CARCINOMA

Phase: PHASE1, PHASE2 • Sponsor: University of Arizona • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

SINONASAL UNDIFFERENTIATED CARCINOMA

Get alerted when new SINONASAL UNDIFFERENTIATED CARCINOMA trials appear

New combo attack on tough cancers: radiation meets targeted drug